Viewing Study NCT05454956


Ignite Creation Date: 2025-12-24 @ 11:29 PM
Ignite Modification Date: 2026-01-05 @ 3:32 AM
Study NCT ID: NCT05454956
Status: COMPLETED
Last Update Posted: 2025-10-01
First Post: 2022-06-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD
Sponsor: Tarsus Pharmaceuticals, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-08-03
Start Date Type: ACTUAL
Primary Completion Date: 2023-05-18
Primary Completion Date Type: ACTUAL
Completion Date: 2023-05-18
Completion Date Type: ACTUAL
First Submit Date: 2022-06-27
First Submit QC Date: None
Study First Post Date: 2022-07-12
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-12-10
Results First Submit QC Date: None
Results First Post Date: 2025-10-01
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-09-11
Last Update Post Date: 2025-10-01
Last Update Post Date Type: ESTIMATED